Huangjinsan ameliorates adenine-induced chronic kidney disease by regulating metabolic profiling
文献类型：期刊论文
| 作者 | Guo, Yuejiao1; Liu, Fang2,3; Chen, MingCang2,3; Tian, Qiang2; Tian, Xiaoting2,3; Xiong, Qiang1; Huang, Chenggang2,3
|
| 刊名 | JOURNAL OF SEPARATION SCIENCE
 |
| 出版日期 | 2021-11-05 |
| 页码 | 11 |
| 关键词 | chronic kidney disease Huangjinsan metabolomics renoprotection traditional Chinese medicine |
| ISSN号 | 1615-9306 |
| DOI | 10.1002/jssc.202100542 |
| 通讯作者 | Xiong, Qiang(xiongqiang@njtech.edu.cn) ; Huang, Chenggang(cghsimm@126.com) |
| 英文摘要 | Chronic kidney disease is an increasingly serious public health problem worldwide. Our recent studies have shown that Huangjinsan has a renal protective effect on chronic kidney disease, but the specific mechanism by which this effect occurs is not clear. To study the therapeutic effect of Huangjinsan on chronic kidney disease and to explore its possible mechanism of action through nontargeted metabolomics methods, a chronic kidney disease rat model was induced by adenine, and the Huangjinsan extract was given by oral gavage. Body weight, the kidney index, pathological sections, and a series of biochemical indicators were measured. High-performance liquid chromatography quadrupole time-of-flight mass spectrometry was used to analyze the changes in the plasma metabolome. Huangjinsan significantly reduced indicators of kidney damage, including total protein, albumin, the total protein to creatinine ratio, and the albumin to creatinine ratio in urine, as well as IL-2, MCP-1 alpha, and blood urea levels in plasma. Based on nontargeted metabolomics, 13 metabolites related to chronic kidney disease were discovered. These metabolites are closely related to glycerophospholipid metabolism, arginine and proline metabolism, and sphingolipid metabolism. We found that Huangjinsan can restore the renal function of adenine-induced chronic kidney disease by regulating the metabolic profile. |
| WOS关键词 | GLOMERULAR-FILTRATION-RATE ; ALL-CAUSE ; LIPIDS ; ALBUMINURIA ; PROLINE ; TISSUE ; APOPTOSIS ; LPC |
| 资助项目 | Chinese Academy of Science and Technology Service Network Planning[KFJ-STS-QYZD-2021-03-001] ; Youth Innovation Promotion Association of Chinese Academy of Sciences[2019280] ; National Natural Science Foundation of China for Young Scientists[81803828] ; National Natural Science Foundation of China for Young Scientists[81973456] |
| WOS研究方向 | Chemistry |
| 语种 | 英语 |
| WOS记录号 | WOS:000714601000001 |
| 出版者 | WILEY-V C H VERLAG GMBH |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/298778]  |
| 专题 | 中国科学院上海药物研究所 |
| 通讯作者 | Xiong, Qiang; Huang, Chenggang |
| 作者单位 | 1.Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, 30 South Puzhu Rd, Nanjing 211816, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, 501 Hai Ke Rd Zhangjiang, Shanghai 201203, Peoples R China 3.Univ Chinese Acad Sci, Beijing, Peoples R China |
| 推荐引用方式 GB/T 7714 | Guo, Yuejiao,Liu, Fang,Chen, MingCang,et al. Huangjinsan ameliorates adenine-induced chronic kidney disease by regulating metabolic profiling[J]. JOURNAL OF SEPARATION SCIENCE,2021:11. |
| APA | Guo, Yuejiao.,Liu, Fang.,Chen, MingCang.,Tian, Qiang.,Tian, Xiaoting.,...&Huang, Chenggang.(2021).Huangjinsan ameliorates adenine-induced chronic kidney disease by regulating metabolic profiling.JOURNAL OF SEPARATION SCIENCE,11. |
| MLA | Guo, Yuejiao,et al."Huangjinsan ameliorates adenine-induced chronic kidney disease by regulating metabolic profiling".JOURNAL OF SEPARATION SCIENCE (2021):11. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。